ALX Oncology Holdings Inc.ALXONASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank48
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P48
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-2.44%
Q3 202516.33%
Q2 202515.52%
Q1 2025-5.45%
Q4 20245.17%
Q3 202423.68%
Q2 2024-7.04%
Q1 202423.66%
Q4 202325.00%
Q3 2023-47.62%
Q2 2023-20.00%
Q1 20236.67%
Q4 202213.79%
Q3 2022-10.13%
Q2 2022-31.67%
Q1 202214.29%
Q4 2021-14.75%
Q3 2021-52.50%
Q2 2021-14.29%
Q1 202130.00%
Q4 2020-47.06%
Q3 2020-3.03%
Q2 2020-106.25%
Q1 202054.29%
Q4 2019-150.00%
Q3 201926.32%
Q2 20190.00%
Q1 20190.00%